Michel De Pauw
A5087989756- Pulmonary Hypertension Research and Treatments
- Transplantation: Methods and Outcomes
- Systemic Sclerosis and Related Diseases
- Cardiac Arrhythmias and Treatments
- Mechanical Circulatory Support Devices
- Organ Transplantation Techniques and Outcomes
- Cardiac Imaging and Diagnostics
- Cardiac Structural Anomalies and Repair
- Atrial Fibrillation Management and Outcomes
- Cardiovascular Issues in Pregnancy
- Cardiac Valve Diseases and Treatments
- Cardiovascular Function and Risk Factors
- Cardiac electrophysiology and arrhythmias
- Cardiac pacing and defibrillation studies
- Renal Transplantation Outcomes and Treatments
- Venous Thromboembolism Diagnosis and Management
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Cardiac Health and Mental Health
- Infective Endocarditis Diagnosis and Management
- Cardiac tumors and thrombi
- Coronary Interventions and Diagnostics
- Liver Disease and Transplantation
- Stellar, planetary, and galactic studies
- Acute Myocardial Infarction Research
- Vascular Anomalies and Treatments
Ghent University Hospital
2016-2025
Ghent University
1995-2024
Universitair Ziekenhuis Brussel
2010-2021
Karolinska University Hospital
2020
Karolinska Institutet
2020
European Society of Cardiology
2020
Technical University of Munich
2019
Cliniques Universitaires Saint-Luc
2015-2016
Pulmonary Vascular Research Institute
2014
Onze Lieve Vrouwziekenhuis Hospital
1999
Abstract Aims This report from the European Society of Cardiology (ESC) Atlas Project updates and expands upon widely cited 2019 in presenting cardiovascular disease (CVD) statistics for 57 ESC member countries. Methods results Statistics pertaining to 2019, or latest available year, are presented. Data sources include World Health Organization, Institute Metrics Evaluation, Bank, novel sponsored data on human capital infrastructure healthcare delivery. New material this includes...
BACKGROUND Both [13N]ammonia and [15O]water have been used to quantify myocardial blood flow with positron emission tomography using appropriate tracer kinetic models. A direct comparison of the two tracers radioactive microspheres has not performed in same experimental preparation. METHODS AND RESULTS The tested for quantification closed-chest dogs circumflex coronary stenosis or permanent occlusion at rest during adenosine-induced hyperemia. [13N]ammonia- [15O]water-derived values compared...
Portopulmonary hypertension (POPH), a complication of chronic liver disease, may be contraindication to transplantation (LT) because the elevated risk peritransplant and posttransplant morbidity mortality. Because POPH is frequently asymptomatic, screening with echocardiography recommended. The only reliable technique, however, for diagnosing right heart catheterization (RHC). aims this study were evaluate current estimated systolic pulmonary artery pressure (sPAP) cutoff value 30 mm Hg...
Peripartum cardiomyopathy (PPCM) patients refractory to medical therapy and intra-aortic balloon pump (IABP) counterpulsation or in whom weaning from these therapies is impossible, are candidates for a left ventricular assist device (LVAD) as bridge recovery transplant. Continuous-flow LVADs smaller, have better long-term durability associated with outcomes. Extra corporeal membrane oxygenation (ECMO) can be used temporary support cardiogenic shock. The aim of this study was evaluate the...
OBJECTIVE Dysglycemia, in this survey defined as impaired glucose tolerance (IGT) or type 2 diabetes, is common patients with coronary artery disease (CAD) and associated an unfavorable prognosis. This European investigated dysglycemia screening risk factor management of CAD relation to standards guidelines for cardiovascular subjects. RESEARCH DESIGN AND METHODS The Society Cardiology’s Observational Research Programme (ESC EORP) Action on Secondary Primary Prevention by Intervention Reduce...
Screening for pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc) improves outcomes. The DETECT screening algorithm is recommended a high-risk SSc subgroup. This study aims to compare prospectively the positive predictive value of using and 2009 European Society Cardiology/European Respiratory (ESC/ERS) guidelines, their cost-effectiveness an unselected, day-to-day population. Post hoc, according 2015 ESC/ERS guidelines echocardiographic parameters alone ("2015 echo screening")...
Abstract Background and Aims Given limited evidence lack of consensus on donor acceptance for heart transplant (HT), selection practices vary widely across HT centres in the USA. Similar variation likely exists a broader scale—across countries systems—but remains largely unexplored. This study characterized differences populations between USA Eurotransplant—a consortium eight European countries—and their implications system-wide outcomes. Methods Characteristics adult reported donors...
Cirrhotic cardiomyopathy (CCM) is a cardiac complication of cirrhosis primarily presenting as diastolic dysfunction (DD). The original diagnostic criteria from 2005 were updated in 2019. This retrospective study aimed to determine the prevalence and clinical impact DD liver transplantation (LT) candidates. Data 233 adult cirrhotic LT candidates analyzed, echocardiographic data used define all patients using revised criteria. was 72,1% for 6,4% Patients with according older than those without...
Portopulmonary hypertension (POPH) is a part of group 1 pulmonary (pulmonary associated with portal hypertension). Liver transplantation (LTx) may be curative, but usually restricted to patients mild-to-moderate POPH. The presence severe POPH contraindication because the elevated risk peritransplantation and post-transplantation morbidity mortality. This report describes series seven onset moderate (two patients) or (five before LTx, whom six were treated oral vasodilator therapy for...
Objective Cirrhotic cardiomyopathy (CCMP) denotes a chronic cardiac dysfunction in cirrhotic patients. It is characterized by systolic (SD) and diastolic (DD), electromechanical abnormalities, the absence of other diseases. Liver transplantation (LTx) has favourable effect on CCMP, but CCMP itself risk factor. Aims study were (1) to estimate prevalence DD among LTx candidates, (2) compare outcome between patients with without DD, (3) determine if tricuspid regurgitation (TR) predictor...
Following results in open-label studies of rituximab patients with systemic sclerosis, a Belgian three-centre initiative was launched to explore safety and efficacy early, diffuse cutaneous sclerosis (dcSSc).Open-label study 17 early dcSSc, treated two courses rituximab, at month 0 6. Clinical examination, lung function testing, echocardiography, disease activity score (DAS) functional status were performed baseline over 24 months follow-up.Modified Rodnan skin (MRSS) changed significantly...
Background An increasing number of older patients are hospitalised. Prognostic uncertainty causes hospital doctors to be reluctant make the switch from cure care. The Supportive and Palliative Care Indicators Tool (SPICT) has not been validated for prognostication in an hospitalised population. Aim To validate SPICT as a prognostic tool risk dying within one year patients. Design Prospective multicentre study. Premorbid 1-year survival time were assessed. Setting/participants Patients 75...
ObjectiveThe soluble guanylate cyclase stimulator riociguat is approved for the treatment of adult patients with pulmonary arterial hypertension (PAH) and inoperable or persistent/recurrent chronic thromboembolic (CTEPH) following Phase 3 randomized trials. The EXPosurE Registry RiociguaT in (EXPERT) study was designed to monitor long-term safety clinical practice.MethodsEXPERT an international, multicenter, prospective, uncontrolled, non-interventional cohort treated riociguat. Patients...